NASDAQ:OFIXOrthofix Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Orthofix Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $33.95 -0.89 (-2.55 %) (As of 05/26/2020 04:00 PM ET) Add Compare Share Today's Range$33.83Now: $33.95▼$35.2550-Day Range$26.01MA: $32.82▼$36.5452-Week Range$22.11Now: $33.95▼$55.17Volume8,413 shsAverage Volume180,401 shsMarket Capitalization$651.84 millionP/E RatioN/ADividend YieldN/ABeta1.02 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $49.00, Orthofix Medical has a potential upside of 43.5% from its current price of $34.15.Amount of Analyst CoverageOrthofix Medical has received no research coverage in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesOrthofix Medical has received 374 “outperform” votes. (Add your “outperform” vote.)Underperform VotesOrthofix Medical has received 441 “underperform” votes. (Add your “underperform” vote.)Community SentimentOrthofix Medical has received 54.11% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote “Outperform” if you believe OFIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $371,392.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 3.50% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions94.46% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow in the coming year, from ($0.38) to ($0.08) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -136.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -136.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 1.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.04 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:OFIX Previous Symbol CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone214-937-2000Debt Debt-to-Equity Ratio0.06 Current Ratio3.64 Quick Ratio2.38Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$459.95 million Price / Sales1.42 Cash Flow$3.01 per share Price / Cash Flow11.27 Book Value$17.22 per share Price / Book1.97Profitability EPS (Most Recent Fiscal Year)$1.47 Net Income$-28,460,000.00 Net Margins-0.81% Return on Equity7.46% Return on Assets5.11%Miscellaneous Employees1,055 Outstanding Shares19,200,000Market Cap$651.84 million Next Earnings Date8/3/2020 (Estimated) OptionableOptionable NASDAQ:OFIX Rates by TradingView Receive OFIX News and Ratings via Email Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions How has Orthofix Medical's stock been impacted by COVID-19 (Coronavirus)? Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OFIX stock has increased by 11.3% and is now trading at $34.15. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Orthofix Medical? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical. When is Orthofix Medical's next earnings date? Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Orthofix Medical. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc (NASDAQ:OFIX) announced its earnings results on Friday, May, 8th. The medical device company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The medical device company earned $104.82 million during the quarter, compared to analyst estimates of $104.50 million. Orthofix Medical had a positive return on equity of 7.46% and a negative net margin of 0.81%. View Orthofix Medical's earnings history. What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical issued an update on its first quarter 2020 Pre-Market earnings guidance on Thursday, April, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $104-105 million, compared to the consensus revenue estimate of $106.54 million. What price target have analysts set for OFIX? 2 brokers have issued 12 month target prices for Orthofix Medical's shares. Their forecasts range from $42.00 to $56.00. On average, they anticipate Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 43.5% from the stock's current price. View analysts' price targets for Orthofix Medical. Has Orthofix Medical been receiving favorable news coverage? News articles about OFIX stock have trended negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Orthofix Medical earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutOrthofix Medical. Are investors shorting Orthofix Medical? Orthofix Medical saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 352,100 shares, an increase of 47.4% from the April 30th total of 238,900 shares. Based on an average daily trading volume, of 179,600 shares, the short-interest ratio is presently 2.0 days. Approximately 1.9% of the company's stock are short sold. View Orthofix Medical's Current Options Chain. Who are some of Orthofix Medical's key competitors? Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Masimo (MASI). View all competitors. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Exxon Mobil (XOM), Allergan (AGN), Biogen (BIIB), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Edwards Lifesciences (EW) and Intercept Pharmaceuticals (ICPT). Who are Orthofix Medical's key executives? Orthofix Medical's management team includes the following people: Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)Mr. Davide Bianchi, Pres of Global Extremities (Age 54) What is Orthofix Medical's stock symbol? Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX." Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.13%), Paradice Investment Management LLC (5.49%), Paradice Investment Management LLC (5.49%), State Street Corp (3.69%), Morgan Stanley (2.61%) and Polar Asset Management Partners Inc. (2.34%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View institutional ownership trends for Orthofix Medical. Which institutional investors are selling Orthofix Medical stock? OFIX stock was sold by a variety of institutional investors in the last quarter, including Rothschild & Co. Asset Management US Inc., BlackRock Inc., Dalton Greiner Hartman Maher & Co., Deutsche Bank AG, AJO LP, THB Asset Management, Federated Hermes Inc., and Wells Fargo & Company MN. View insider buying and selling activity for Orthofix Medical. Which institutional investors are buying Orthofix Medical stock? OFIX stock was bought by a variety of institutional investors in the last quarter, including Morgan Stanley, Paradice Investment Management LLC, Paradice Investment Management LLC, JPMorgan Chase & Co., Polar Asset Management Partners Inc., Bogle Investment Management L P DE, SG Americas Securities LLC, and First Quadrant L P CA. Company insiders that have bought Orthofix Medical stock in the last two years include James F Hinrichs, Jon Carl Serbousek, and Ronald A Matricaria. View insider buying and selling activity for Orthofix Medical. How do I buy shares of Orthofix Medical? Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Orthofix Medical's stock price today? One share of OFIX stock can currently be purchased for approximately $34.15. How big of a company is Orthofix Medical? Orthofix Medical has a market capitalization of $655.68 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe. What is Orthofix Medical's official website? The official website for Orthofix Medical is www.orthofix.com. How can I contact Orthofix Medical? Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected] This page was last updated on 5/26/2020 by MarketBeat.com Staff
